title: The challenge of managing mild Parkinson's disease.
abstract: Clinicians have a number of options when diagnosing and managing Parkinson's disease. The decision to start pharmacotherapy often depends on the particular needs of the patient and careful weighing of possible benefits, cost, and adverse outcomes. Even mild parkinsonism may require the input of a specialist to obtain the best results.
authors.affiliation: Department of Neurology, Wayne State University School of Medicine, Detroit, Michigan, USA.
authors.forename: P A
authors.initials: PA
authors.lastname: LeWitt
mesh_terms: D000978:Antiparkinson Agents / Q000627:therapeutic use*; D018491:Dopamine Agonists / Q000627:therapeutic use*; D006801:Humans; D010300:Parkinson Disease / Q000175:diagnosis / Q000188:drug therapy*; D012720:Severity of Illness Index
chemical_list: D000978:Antiparkinson Agents; D018491:Dopamine Agonists